SMMT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. No worries on liquidiy or solvency for SMMT as it has an excellent financial health rating, but there are worries on the profitability. SMMT is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

In the past year SMMT has reported negative net income.
SMMT had a negative operating cash flow in the past year.
SMMT had negative earnings in each of the past 5 years.
SMMT had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

SMMT's Return On Assets of -50.81% is in line compared to the rest of the industry. SMMT outperforms 49.52% of its industry peers.
SMMT has a better Return On Equity (-56.93%) than 63.24% of its industry peers.

		Industry Rank	Sector Rank
ROA	-50.81%
ROE	-56.93%
ROIC	N/A

ROA(3y)-121.89%

ROA(5y)-99.04%

ROE(3y)-303.53%

ROE(5y)-216.65%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for SMMT so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

SMMT has more shares outstanding than it did 1 year ago.
The number of shares outstanding for SMMT has been increased compared to 5 years ago.
There is no outstanding debt for SMMT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

SMMT has an Altman-Z score of 153.56. This indicates that SMMT is financially healthy and has little risk of bankruptcy at the moment.
SMMT's Altman-Z score of 153.56 is amongst the best of the industry. SMMT outperforms 99.43% of its industry peers.
There is no outstanding debt for SMMT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	153.56

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

SMMT has a Current Ratio of 10.15. This indicates that SMMT is financially healthy and has no problem in meeting its short term obligations.
SMMT has a Current ratio of 10.15. This is amongst the best in the industry. SMMT outperforms 81.52% of its industry peers.
A Quick Ratio of 10.15 indicates that SMMT has no problem at all paying its short term obligations.
The Quick ratio of SMMT (10.15) is better than 81.52% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	10.15
Quick Ratio	10.15

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

SMMT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -122.22%.

EPS 1Y (TTM)-122.22%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-287.5%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, SMMT will show a very strong growth in Earnings Per Share. The EPS will grow by 47.12% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y-297.74%

EPS Next 2Y-76.71%

EPS Next 3Y-41.31%

EPS Next 5Y47.12%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

SMMT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SMMT. No positive earnings are expected for the next year.